Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity-Reference-Cited by-同舟云学术

Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity

Published:2007-06 Issue:3 Volume:118 Page:406-407
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Garcia José A.P.,Simvoulidis Luiz F.N.,Salluh Jorge I.F.,Hansen Maria H.A.,Feres Guilherme A.,Holanda Gustavo S.,Souza Roberto C.S.,Toscano Luisa,Soares Márcio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Doxorubicin-induced cardiomyopathy;Singal;N Engl J Med,1998

2. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO-study): a randomised double-blind trial;Follath;Lancet,2002

3. The role of Ca++-sensitizers for the treatment of heart failure;Lehmann;Curr Opin Crit Care,2003

4. Levosimendan in septic cardiac failure;Noto;Intensive Care Med,2005

5. Successful use of levosimendan in a patient with peripartum cardiomyopathy;Benlolo;Anesth Analg,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy;Cardiovascular Research;2019-06-22

2. Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report;Heart & Lung;2017-09

3. Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy;Cardiology Journal;2016-12-14

4. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer;Cochrane Database of Systematic Reviews;2016-08-23

5. Coronary artery disease in radiotherapy;International Journal of Cardiology;2013-10